Effect of inhaler design variables on paediatric use of dry powder inhalers

Anne J Lexmond1, Tonnis J Kruizinga1, Paul Hagedoorn1

  • 1Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.

Plos One
|June 6, 2014
PubMed

Insights

Developing effective pediatric dry powder inhalers (DPIs) requires understanding airflow resistance and mouthpiece design. Medium-high resistance and specific mouthpiece shapes are suitable and preferred by children aged 5-12.

Area of Science:

  • Pulmonary drug delivery
  • Pediatric respiratory devices
  • Inhaler technology

Background:

  • Dry powder inhaler (DPI) performance is highly dependent on patient inspiratory maneuvers, posing challenges for pediatric use.
  • Previous studies on pediatric DPIs often focused on specific devices or limited inspiratory parameters.

Purpose of the Study:

  • To broadly investigate the requirements for a pediatric DPI using an instrumented test inhaler.
  • To assess the impact of airflow resistance on children's inspiratory flow profiles.
  • To evaluate children's preferences for airflow resistance and mouthpiece design in relation to suitability.

Main Methods:

  • Tested 98 children (aged 4.7-12.6 years) using an instrumented test inhaler across five airflow resistances.
  • Recorded and analyzed inspiratory flow profiles, calculating key inspiratory flow parameters.
  • Utilized a sinuscope to identify oral cavity obstructions during inhalation.

Main Results:

  • Both airflow resistance and child characteristics significantly influenced inspiratory parameters.
  • Medium-high airflow resistance was found to be suitable and preferred by children aged 5-12 years.
  • High incidences of oral obstructions (up to 90%) were observed, potentially limiting DPI use, though an oblong mouthpiece improved oral passageway.

Conclusions:

  • A pediatric DPI should achieve a high fine particle dose within 0.5 L inhaled volume and a peak inspiratory flow rate of 25-40 L/min for children aged 5+.
  • Future pediatric inhaler development should consider these findings regarding airflow resistance, mouthpiece design, and potential obstructions.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
544
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552